from the audited accounts!!!
Commercial Activities
Genentech
In December 2015, Phylogica announced an extension to its research collaboration with Genentech, a subsidiary of the Roche group, to discover novel antibiotics to treat drug resistant superbugs. Under the terms of the agreement Phylogica received an upfront payment of US$500,000 (~AU $598,000) and is eligible to receive discovery, development, and c.....
Talk about fwd looking statements - we havent even got there yet. just another audited accounts error.
from the audited accounts!!! Commercial Activities Genentech In...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |